North America Biopharmaceutical Logistics Market Size & Outlook, 2025-2033
North America Biopharmaceutical Logistics Market Insights
- According to Reed Intelligence analysis, the North America Biopharmaceutical Logistics Market size stood at USD 56187.76 Million in 2024 and is forecasted to reach USD 101317.6 Million by 2033.
- The market is projected to grow at a CAGR of 6.77% between 2025 and 2033.
- By segment, Cold Chain was the leading By Supply Chain in terms of market size in 2024.
- Cold Chain is expected to be the most lucrative By Supply Chain segment, exhibiting the fastest growth throughout the forecast period.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- North America held 39.24% share of the global Biopharmaceutical Logistics Market size in 2024.
- United States is expected to remain the largest contributor to the global market size by 2033.
- By 2033, Canada is anticipated to record the highest growth in North America, with the market size expected to reach USD 25433.02 Million.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 56187.76 Million |
| Market Size In 2033 | USD 101317.6 Million |
| Largest segment | Cold Chain |
| Units | Revenue in USD Million |
| CAGR | 6.77% (2025-2033) |
| Segmnetation Covered | |
| North America |
|
| By Supply Chain |
|
| By Services |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
North America Biopharmaceutical Logistics Market Country 2025-2033 (USD Million)
| North America | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | XX.x | XX.x | XX.x | 42107.11 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Canada | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
North America Biopharmaceutical Logistics Market By Supply Chain 2025-2033 (USD Million)
| By Supply Chain | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cold Chain | XX.x | XX.x | XX.x | 31380.86 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Non-Cold Chain | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
North America Biopharmaceutical Logistics Market By Services 2025-2033 (USD Million)
| By Services | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mode of Transportation | XX.x | XX.x | XX.x | 25284.49 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Warehousing | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
